Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Jun 21, 2022 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
0001140361-22-023577.pdf
0001140361-22-023577.rtf
0001140361-22-023577.xls
Feb 16, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001213900-21-009652.pdf
0001213900-21-009652.rtf
0001213900-21-009652.xls
Feb 06, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001437749-23-002597.pdf
0001437749-23-002597.rtf
Feb 14, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0000080255-23-002724.pdf
0000080255-23-002724.rtf
Feb 14, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001104659-23-021810.pdf
0001104659-23-021810.rtf
0001104659-23-021810.xls
Jul 12, 2022 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
0001140361-22-025852.pdf
0001140361-22-025852.rtf
0001140361-22-025852.xls
Jul 18, 2022 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
0001140361-22-026236.pdf
0001140361-22-026236.rtf
0001140361-22-026236.xls
Jul 24, 2020 S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
0001213900-20-018584.pdf
0001213900-20-018584.rtf
0001213900-20-018584.xls
Jul 28, 2020 S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
0001213900-20-018906.pdf
0001213900-20-018906.rtf
0001213900-20-018906.xls
Mar 31, 2022 10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML
0001213900-22-016826.pdf
0001213900-22-016826.rtf
0001213900-22-016826.xls
EX-101.INS - XBRL INSTANCE FILE

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer